Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine

J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e546-e548. doi: 10.1111/jdv.17342. Epub 2021 May 29.

Authors

B M Cyrenne¹, F Al-Mohammedi¹, J G DeKoven¹, R Alhusayen¹

Affiliation

¹ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

No abstract available

Publication types

Letter

MeSH terms

BNT162 Vaccine
COVID-19 Vaccines
COVID-19*
Humans
Pityriasis Rosea* / chemically induced
RNA, Messenger
SARS-CoV-2
Vaccination / adverse effects

Substances

COVID-19 Vaccines
RNA, Messenger
BNT162 Vaccine